About C4X Discovery
C4X Discovery is a company based in Manchester (United Kingdom) founded in 2008. The company has 46 employees as of June 30, 2021. C4X Discovery has completed 1 acquisition, including Adorial. C4X Discovery offers products and services including Conformetrix Platform and PatientSeek Platform. C4X Discovery operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Insitro, BridgeBio and ATAI, among others.
- Headquarter Manchester, United Kingdom
- Employees 46 as on 30 Jun, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name C4x Discovery Holdings Plc
- Date of Incorporation 16 Jul, 2014
- Jurisdiction MANCHESTER
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of C4X Discovery
C4X Discovery offers a comprehensive portfolio of products and services, including Conformetrix Platform and PatientSeek Platform.
Enables rational drug design with 4D structural data for immuno-inflammatory treatments.
Provides genetics-led insights for patient response prediction in therapies.
People of C4X Discovery
Unlock access to complete
Unlock access to complete
Funding Insights of C4X Discovery
Investors in C4X Discovery
C4X Discovery has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Astrazeneca and Calculus Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Adams Plc is focused on special situation investment opportunities.
|
Locked | Locked | Locked | |
|
UK venture capital investments are managed by Calculus Capital.
|
Locked | Locked | Locked |
Investor details for C4X Discovery
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by C4X Discovery
C4X Discovery has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Adorial.
Investment portfolio details for C4X Discovery
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Proprietary in silico genomics platform is utilized for drug discovery.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for C4X Discovery
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - C4X Discovery
Detailed financials for C4X Discovery
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
C4x Discovery Comparisons
Peer comparison for C4X Discovery
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of C4X Discovery
C4X Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Insitro, BridgeBio and ATAI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
Detailed competitors of C4X Discovery
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on C4x Discovery
Complete news archive for C4X Discovery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about C4X Discovery
C4X Discovery was founded in 2008 and raised its 1st funding round 1 year after it was founded.
C4X Discovery is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
As of Jun 30, 2021, the latest employee count at C4X Discovery is 46.
Annual revenue of C4X Discovery is $7.65M as on Jul 31, 2021.
Founded in 2008 and based in Manchester, United Kingdom, operations focus on the biotechnology sector through drug discovery and design. Proprietary software platforms, including Taxonomy3 for human genetics analysis and Conformetrix for determining 3D molecular shapes, are utilized alongside NMR technology for candidate optimization. A pipeline includes treatments for addiction, diabetes, inflammation, and oncology.
C4X Discovery's top competitors include Jazz Pharmaceuticals, BridgeBio and C4 Therapeutics.
C4X Discovery offers Conformetrix Platform and PatientSeek Platform.
C4X Discovery has made 1 acquisition, including Adorial.
C4X Discovery has 7 investors. Key investors include Gov.uk, Astrazeneca, Calculus Capital, Polar Capital, and Panmure Gordon.